P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM). (23rd June 2022) - Sperling, A. S.; Nikiforow, S.; Derman, B.; Nadeem, O.; Mo, C.; Laubach, J.; Anderson, K.; Alonso, A.; Im, S.-Y.; Ikwgawa, S.; Prabhala, R.; Hernandez Rodriduez, D.; et al.